ALLO — Allogene Therapeutics Inc
In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in Allogene Therapeutics Inc (ALLO), worth $8.94M combined. Over the quarter 3 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $7.98M | 0.01% | +79.2% |
| BIT | $478.40K | 0.02% | NEW |
| Quadrature | $437.82K | 0.00% | +158.5% |
| Polymer | $47.44K | 0.00% | -77.3% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.